Skip to main content

Why Do Clinical Research?

  • Chapter
  • First Online:
Developing a Successful Clinical Research Program

Abstract

We need more good clinical research sites in the United States. If a drug, device, or treatment is to be approved in the United States, it needs to be tested in a sample representative of the entire population, including children and the elderly, both genders, all races and ethnicities, in patients with concomitant illnesses and medications, and those living in urban and rural environments. Reasons to participate in clinical research include enrolling a widely generalizable population in clinical research, involve enlightened clinical research personnel and protocols in the work being done, and meaningfully contribute to how medicine is practiced today.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Liu KA, Dipietro Mager NA. Women’s involvement in clinical trials: historical perspective and future implications. Pharm Pract. 2016;14(1):708. https://doi.org/10.18549/PharmPract.2016.01.708.

    Article  Google Scholar 

  2. Watts G. Why the exclusion of older people from clinical research must stop. Brit med Journal 2012; 344: e 3445.

    Google Scholar 

  3. http://grants.nih.gov/grants/guide/notice-files/not94-100.html. NIH guidelines on the inclusion of women and minorities as subjects in clinical research. n.d.

  4. https://grants.nih.gov/grants/guide/notice-files/NOT-OD-02-001.html. n.d.

  5. US Food and Drug Administration. The Pediatric Exclusivity Provision. Jan 2001. Status report to Congress. https://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/.

  6. Husten L. AstraZeneca: Ticagreor (Brilinta) gains FDA approval?. CardioBrief. 2011. Blog at WordPress.com.

  7. Press Release. Mar 28, 2018. First vaccine approved by FDA to prevent serogroup B meningococcal disease. https://fda.gov/NewsEvents.

  8. Mac Kenzie WF, Garner F. Comparison of neoplasms in six sources of rats. J Natl Cancer Inst. 1973;50(5):1243–57.

    Article  CAS  PubMed  Google Scholar 

  9. Wilson J. Viagra: The little pill that could. CNN. 2013. https://cnn.com/2013/03/27/health/viagra-anniversary-timeline/

    Google Scholar 

  10. Fintel B, Samzras AT, Carias E. The thalidomide tragedy: lessons for drug safety and regulation. 2009. https://helix.northwestern.edu/article/thalidomide-tragedy-lessons.

    Google Scholar 

  11. Palumbo A, Bringhen S, Caravita T, Merla E, Capparella V, Callea V, Cangialosi C, Grasso M, Rossini F, Galli M, Catalano L. Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomized controlled trial. Lancet. 2006;367:825–31.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

East, C. (2018). Why Do Clinical Research?. In: Developing a Successful Clinical Research Program. Springer, Cham. https://doi.org/10.1007/978-3-319-54693-3_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-54693-3_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-54692-6

  • Online ISBN: 978-3-319-54693-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics